These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 5606293)
1. [Experience in the use of the new Soviet preparation Amorphin (Fruticin) for the prevention of attacks of paroxysmal tachycardia]. Moiseev SG; Ustinova EZ Sov Med; 1967 Dec; 30(12):53-6. PubMed ID: 5606293 [No Abstract] [Full Text] [Related]
2. [Use of Coritrate in the prevention of paroxysmal tachycardia]. Homola D; Srnová V; Rotrekl J Vnitr Lek; 1973 Sep; 19(9):860-5. PubMed ID: 4583399 [No Abstract] [Full Text] [Related]
3. [Paroxysmal tachycardia in childhood--diagnosis, therapy and prophylaxis]. Bock K Kinderarztl Prax; 1967 Aug; 35(8):343-50. PubMed ID: 5602230 [No Abstract] [Full Text] [Related]
4. [On the clinical trial of disopyramide (Rhythmodan) in the prevention of attacks of supraventricular paroxysmal tachycardia]. Masini G Minerva Med; 1970 Sep; 61(71 Suppl):3748-52. PubMed ID: 5454440 [No Abstract] [Full Text] [Related]
5. [Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima]. Kedra M; Kedrowa S Pol Tyg Lek; 1968 May; 23(19):714-6. PubMed ID: 4876207 [No Abstract] [Full Text] [Related]
7. The usefulness of intravenous lanatoside C in paroxysmal ventricular tachycardia not due to myocardial infarction. SHAPIRO E; WEINER H; BERNSTEIN JL Perm Found Med Bull; 1952 Aug; 10(1-4):27-38. PubMed ID: 14948359 [No Abstract] [Full Text] [Related]
8. [Guanethidine in the Wolff-Parkinson-White syndrome. Prevention and treatment of the paroxysmal tachycardia crisis]. Cragnolino HJ; Podio C; Gagliardi J; Rodríguez OE; Ryba D Prensa Med Argent; 1965 Nov; 52(43):2759-62. PubMed ID: 5882384 [No Abstract] [Full Text] [Related]
9. [Indications and contraindications for therapy with cardiac glycosides]. Haasis R Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303 [TBL] [Abstract][Full Text] [Related]
10. [Effect of continuous cardiac pacing on the incidence of ectopic tachycardia in the sick sinus syndrome]. Kutarski A; Widomska-Czekajska T; Dubejko J; Pieniazek M Pol Tyg Lek; 1981 Oct; 36(41):1565-8. PubMed ID: 7335535 [No Abstract] [Full Text] [Related]
11. [On clinical assessment of the new Soviet glycoside Erysimosid]. Pishchulina ES Ter Arkh; 1966 Jul; 38(7):77-9. PubMed ID: 5999741 [No Abstract] [Full Text] [Related]
12. [Prevention of frequent paroxysmal ventricular tachycardia by combined use of anti-arrhythmia drugs]. Kesler DF Klin Med (Mosk); 1981 Nov; 59(11):98-9. PubMed ID: 7321509 [No Abstract] [Full Text] [Related]
13. [Clinical experience with a new cardiac glycoside]. Büsscher K Z Allgemeinmed; 1969 Feb; 45(6):265-8. PubMed ID: 5801646 [No Abstract] [Full Text] [Related]
14. [Clinical experience with the new cardiac glycoside peruvosid]. Pfund WD Hippokrates; 1969 Aug; 40(16):646-53. PubMed ID: 5810178 [No Abstract] [Full Text] [Related]
15. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the relationships between the glycoside dosage effect and pulse frequency behavior]. Döring D; Wenzel V Z Gesamte Inn Med; 1966 Jun; 21(12):Suppl:137-8. PubMed ID: 5987624 [No Abstract] [Full Text] [Related]